Hims & Hers Files 8-K

TL;DR

HIMS filed an 8-K on 9/9 for an event on 9/5. Details pending.

AI Summary

Hims & Hers Health, Inc. filed an 8-K on September 9, 2024, reporting an event that occurred on September 5, 2024. The filing pertains to "Other Events" and "Financial Statements and Exhibits." No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This filing indicates a regulatory update from Hims & Hers Health, Inc. to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific financial or operational details that would indicate high risk.

Key Players & Entities

• Hims & Hers Health, Inc. (company) — Registrant
• September 5, 2024 (date) — Earliest event reported
• September 9, 2024 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• 2269 Chestnut Street , #523 San Francisco , CA 94123 (address) — Principal executive offices

FAQ

From the Filing

0001104659-24-098228.txt : 20240909 0001104659-24-098228.hdr.sgml : 20240909 20240909171357 ACCESSION NUMBER: 0001104659-24-098228 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240905 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240909 DATE AS OF CHANGE: 20240909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 241287985 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 8-K 1 tm2422489d3_8k.htm FORM 8-K false 0001773751 0001773751 2024-09-05 2024-09-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM  8-K       CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): September 5, 2024       HIMS & HERS HEALTH, INC. (Exact name of registrant as specified in its charter)       Delaware 001-38986 98-1482650 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)     2269 Chestnut Street , #523 San Francisco , CA 94123 (Address of principal executive offices)   ( 415 ) 851-0195 (Registrant’s telephone number, including area code)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol   Name of each exchange on which registered Class A Common Stock, $0.0001 par value   HIMS   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).   Emerging growth company ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨             Item 8.01 Other Events.   On September 9, 2024, Hims & Hers Health, Inc. (the “Company”) filed a prospectus supplement dated September 9, 2024 (the “Prospectus Supplement”), which forms part of the Company’s automatic “shelf” Registration Statement on Form S-3 (File No. 333-282008), which was filed on September 9, 2024 with the Securities and Exchange Commission. The Prosp